Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
55,990,706
-
Shares change
-
+2,269,500
-
Total reported value, excl. options
-
$92,402,857
-
Value change
-
+$4,082,986
-
Put/Call ratio
-
306591%
-
Number of buys
-
28
-
Number of sells
-
19
-
Price
-
$1.65
Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q3 2024
As of 30 Sep 2024 IMMUNIC, INC. - Common Stock (IMUX) had 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,990,706 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Avidity Partners Management LP, Soleus Capital Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, RTW INVESTMENTS, LP, Colony Group, LLC, Omega Fund Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 71 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.